Robert E. Pollack
Corporate Officer/Principal at The Trustees of Columbia University in The City of New York
Profile
Robert E.
Pollack is a Professor at The Trustees of Columbia University in The City of New York.
He was previously a Director at Tapestry Pharmaceuticals, Inc., NXXI, Inc., and Mirabilis Ventures, Inc.
Robert E. Pollack active positions
Companies | Position | Start |
---|---|---|
The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Former positions of Robert E. Pollack
Companies | Position | End |
---|---|---|
Mirabilis Ventures, Inc.
Mirabilis Ventures, Inc. Investment ManagersFinance Mirabilis Ventures, Inc. is a private equity fund based in Orlando, Florida. | Director/Board Member | 27/05/2008 |
Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Director/Board Member | 04/02/2008 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Director/Board Member | 06/04/2005 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | Health Technology |
Mirabilis Ventures, Inc.
Mirabilis Ventures, Inc. Investment ManagersFinance Mirabilis Ventures, Inc. is a private equity fund based in Orlando, Florida. | Finance |
Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Health Technology |
- Stock Market
- Insiders
- Robert E. Pollack